STOCK TITAN

Vanguard disaggregates holdings; reports 0 shares in Bruker (NYSE: BRKR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bruker Corp — Amendment No. 8 to a Schedule 13G/A was filed reporting that The Vanguard Group beneficially owns 0 shares of Bruker Corp common stock, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries or business divisions to report ownership separately. The filer states Vanguard no longer is deemed to beneficially own securities held by those subsidiaries/divisions. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Filing records zero beneficial ownership after Vanguard internal disaggregation.

The amendment reports 0 shares and 0% beneficial ownership for The Vanguard Group in Bruker Corp following an internal reorganization referenced to SEC Release No. 34-39538.

This change is procedural: the filing documents reporting separation of subsidiaries and does not by itself alter Bruker’s capitalization or immediate market overhang. Subsequent filings from the listed subsidiaries may show holdings.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does the Schedule 13G/A amendment say about Vanguard's ownership of BRKR?

It states The Vanguard Group beneficially owns 0 shares of Bruker Corp, equal to 0% of the class. The filing attributes this to a January 12, 2026 internal realignment that disaggregated reporting by certain Vanguard subsidiaries or business divisions.

Why did The Vanguard Group report zero ownership for BRKR in this filing?

Because of an internal realignment on January 12, 2026, Vanguard disaggregated certain subsidiaries/divisions under SEC Release No. 34-39538. As a result, The Vanguard Group no longer is deemed to beneficially own securities held by those entities.

Does this amendment mean Bruker issued or retired shares?

No. The amendment documents reporting changes by Vanguard and does not indicate any issuance or retirement of Bruker shares. It only states Vanguard’s beneficial ownership is reported as 0 shares after the realignment.

Who signed the Schedule 13G/A amendment for Vanguard on BRKR?

The filing is signed by Ashley Grim, Head of Global Fund Administration, with the signature date shown as 03/26/2026. The signature certifies the accuracy of the reported ownership information.

Will Vanguard subsidiaries still hold BRKR shares after this amendment?

The filing indicates certain Vanguard subsidiaries or business divisions may hold securities and will report separately. It states the subsidiaries pursue previous investment strategies and will report beneficial ownership on a disaggregated basis.
Bruker Corp

NASDAQ:BRKR

View BRKR Stock Overview

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

5.45B
103.04M
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA